93 related articles for article (PubMed ID: 34716835)
1. The Role of Families in Adolescent and Young Adults' PrEP Use.
Atujuna M; Montgomery ET; Hartmann M; Ndwayana S; Browne EN; Sindelo S; Bekker LG; Minnis AM
AIDS Behav; 2022 May; 26(5):1618-1632. PubMed ID: 34716835
[TBL] [Abstract][Full Text] [Related]
2. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
[TBL] [Abstract][Full Text] [Related]
3. The Effect of PrEP Use Disclosure on Adherence in a Cohort of Adolescent Girls and Young Women in South Africa.
Giovenco D; Pettifor A; Powers KA; Hightow-Weidman L; Pence BW; Edwards JK; Gill K; Morton JF; van der Straten A; Celum C; Bekker LG
AIDS Behav; 2022 Apr; 26(4):1007-1016. PubMed ID: 34478015
[TBL] [Abstract][Full Text] [Related]
4. Pre-exposure prophylaxis as an opportunity for engagement in HIV prevention among South African adolescents.
LoVette A; Kuo C; Giovenco D; Hoare J; Underhill K; Operario D
SAHARA J; 2022 Dec; 19(1):1-7. PubMed ID: 35135437
[TBL] [Abstract][Full Text] [Related]
5. Exploring adults as support persons for improved pre-exposure prophylaxis for HIV use among select adolescents and young adults in the Deep South.
Hill SV; Johnson J; Rahman F; Dauria EF; Mugavero M; Matthews LT; Simpson T; Elopre L
PLoS One; 2021; 16(3):e0248858. PubMed ID: 33740005
[TBL] [Abstract][Full Text] [Related]
6. Delivering PrEP to Young Women in a Low-Income Setting in South Africa: Lessons for Providing Both Convenience and Support.
Cassidy T; Ntuli N; Kilani C; Malabi N; Rorwana B; Mutseyekwa T; O'Connell R; Steele SJ; Ndlovu Z; Ellman T; de Azevedo V; Pfaff C; Nelson A; Duran LT
AIDS Behav; 2022 Jan; 26(1):147-159. PubMed ID: 34259963
[TBL] [Abstract][Full Text] [Related]
7. A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa.
Dietrich JJ; Atujuna M; Tshabalala G; Hornschuh S; Mulaudzi M; Koh M; Ahmed N; Muhumuza R; Ssemata AS; Otwombe K; Bekker LG; Seeley J; Martinson NA; Terris-Prestholt F; Fox J
BMC Health Serv Res; 2021 Jan; 21(1):17. PubMed ID: 33407395
[TBL] [Abstract][Full Text] [Related]
8. Influences on PrEP Uptake and Adherence Among South African Women During Periconception and Pregnancy: A Qualitative Analysis.
Wyatt MA; Pisarski EE; Kriel Y; Smith PM; Mathenjwa M; Jaggernath M; Smit JA; Matthews LT; Ware NC
AIDS Behav; 2023 Jan; 27(1):208-217. PubMed ID: 35771311
[TBL] [Abstract][Full Text] [Related]
9. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.
Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C
AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053
[TBL] [Abstract][Full Text] [Related]
10. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
Celum C; Hosek S; Tsholwana M; Kassim S; Mukaka S; Dye BJ; Pathak S; Mgodi N; Bekker LG; Donnell DJ; Wilson E; Yuha K; Anderson PL; Agyei Y; Noble H; Rose SM; Baeten JM; Fogel JM; Adeyeye A; Wiesner L; Rooney J; Delany-Moretlwe S
PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779
[TBL] [Abstract][Full Text] [Related]
11. The PrEP Journey: Understanding How Internal Drivers and External Circumstances Impact The PrEP Trajectory of Adolescent Girls and Young Women in Cape Town, South Africa.
O'Rourke S; Hartmann M; Myers L; Lawrence N; Gill K; Morton JF; Celum CL; Bekker LG; van der Straten A
AIDS Behav; 2021 Jul; 25(7):2154-2165. PubMed ID: 33521908
[TBL] [Abstract][Full Text] [Related]
12. Identifying Missed Opportunities for Human Immunodeficiency Virus Pre-exposure Prophylaxis During Preventive Care and Reproductive Visits in Adolescents in the Deep South.
Hill SV; Westfall AO; Coyne-Beasley T; Simpson T; Elopre L
Sex Transm Dis; 2020 Feb; 47(2):88-95. PubMed ID: 31934955
[TBL] [Abstract][Full Text] [Related]
13. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial.
Celum CL; Gill K; Morton JF; Stein G; Myers L; Thomas KK; McConnell M; van der Straten A; Baeten JM; Duyver M; Mendel E; Naidoo K; Dallimore J; Wiesner L; Bekker LG
J Int AIDS Soc; 2020 Nov; 23(11):e25636. PubMed ID: 33247553
[TBL] [Abstract][Full Text] [Related]
14. Disclosure of PrEP use by young women in South Africa and Tanzania: qualitative findings from a demonstration project.
Scorgie F; Khoza N; Baron D; Lees S; Harvey S; Ramskin L; Stangl A; Colombini M; Mashauri E; Delany-Moretlwe S;
Cult Health Sex; 2021 Feb; 23(2):257-272. PubMed ID: 32129720
[TBL] [Abstract][Full Text] [Related]
15. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.
Gill K; Johnson L; Dietrich J; Myer L; Marcus R; Wallace M; Pidwell T; Mendel E; Fynn L; Jones K; Wiesner L; Slack C; Strode A; Spiegel H; Hosek S; Rooney J; Gray G; Bekker LG
Lancet Child Adolesc Health; 2020 Dec; 4(12):875-883. PubMed ID: 33222803
[TBL] [Abstract][Full Text] [Related]
16. Adherence to Pre-Exposure Prophylaxis in Adolescents and Young Adults: A Systematic Review and Meta-Analysis.
Allison BA; Widman L; Stewart JL; Evans R; Perry M
J Adolesc Health; 2022 Jan; 70(1):28-41. PubMed ID: 34059426
[TBL] [Abstract][Full Text] [Related]
17. Initiation of HIV pre-exposure prophylaxis in adolescents and young adults: Barriers and opportunities.
Mocorro I; Sandhu PJ; Rowniak S; Leonard A
J Am Assoc Nurse Pract; 2020 Aug; 33(9):700-708. PubMed ID: 32804806
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
Mansoor LE; Lewis L; Naicker CL; Harkoo I; Dawood H; Naidoo K; Gengiah TN; Samsunder N; Beesham I; Abdool Karim SS; Abdool Karim Q
J Int AIDS Soc; 2022 Jul; 25(7):e25957. PubMed ID: 35785472
[TBL] [Abstract][Full Text] [Related]
19. Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial.
Nash S; Dietrich J; Ssemata AS; Herrera C; O'Hagan K; Else L; Chiodi F; Kelly C; Shattock R; Chirenje M; Lebina L; Khoo S; Bekker LG; Weiss HA; Gray C; Stranix-Chibanda L; Kaleebu P; Seeley J; Martinson N; Fox J;
Trials; 2020 Oct; 21(1):900. PubMed ID: 33121503
[TBL] [Abstract][Full Text] [Related]
20. "Adolescents do not only require ARVs and adherence counseling": A qualitative investigation of health care provider experiences with an HIV youth peer mentoring program in Ndola, Zambia.
Abrams EA; Burke VM; Merrill KG; Frimpong C; Miti S; Mwansa JK; Denison JA
PLoS One; 2021; 16(6):e0252349. PubMed ID: 34106967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
